Natural Biocon Financials

BSE: 543207

₹3.56

₹0.01 (0.28%)

As on 02-Sep-2026IST

Market cap

₹9 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	0.88	8.35	13.53	1.25	0.48	0.13
Total Income	0.88	8.35	13.53	1.25	0.48	0.13
Total Expenditure	1.07	8.29	13.31	1.01	0.39	0.13
EBITDA	-0.19	0.06	0.23	0.25	0.09	0.00
Depreciation	0.00	0.00	--	--	--	--
EBIT	-0.19	0.06	0.23	0.25	0.09	0.00
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.19	0.06	0.23	0.25	0.09	0.00
Provision for Tax	--	0.02	0.07	0.07	0.02	0.00
Profit after Tax	-0.19	0.04	0.15	0.18	0.07	0.00

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	30.73	31.87	12.38	12.23	12.05	11.99
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	6.11	6.65	4.38	1.29	0.25	0.39
Total Liabilities	36.84	38.52	16.77	13.52	12.30	12.38

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	31.60	31.48	10.38	11.37	11.37	10.59
Current Assets	5.24	7.04	6.39	2.15	0.93	1.79
Total Assets	36.84	38.52	16.77	13.52	12.30	12.38
Total Debt*	--	0.28	0.07	0.15	0.17	0.36
Net Current Assets	-0.87	0.39	2.01	0.86	0.68	1.40
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	1.30	-0.12	0.21	0.19	0.32
Cash Flow from Investing Activities	--	-21.11	--	--	--	--
Cash from Financing Activities	--	19.67	-0.09	-0.02	-0.02	-0.32
Net Cash Inflow / Outflow	--	-0.14	-0.21	0.19	0.17	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.07	0.02	0.13	0.16	0.06	0.00
Cash EPS (₹)	-0.07	0.02	0.13	0.16	0.06	0.00
Adjusted Book Value (₹)	11.91	12.36	10.89	10.75	10.60	10.54
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.50	-0.11	0.19	0.17	0.29
Free Cash Flow per Share (₹)	--	0.50	-0.11	0.19	0.16	0.29

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	0.27	1.82	2.02	0.72	0.03
ROE (%)	-0.61	0.20	1.24	1.48	0.55	0.02
ROA (%)	-0.50	0.16	1.01	1.39	0.53	0.02
EBIT Margin (%)	-21.75	0.72	1.67	19.79	18.43	3.23
Net Margin (%)	-21.62	0.53	1.13	14.28	13.68	2.08
Cash Profit Margin (%)	0.00	0.54	1.13	14.28	13.68	2.08

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-90.28	-38.32	978.97	160.34	265.24	--
EBIT Growth (%)	-291.00	-73.25	-8.87	179.55	1,983.04	113.49
Net Profit Growth (%)	-290.00	-70.77	-14.77	171.77	2,296.71	108.68
EPS Growth (%)	-290.70	-87.11	-14.79	172.02	2,312.50	108.62
Book Value Growth (%)	--	157.37	1.25	1.49	0.55	0.02

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-48.31	857.80	76.07	29.46	156.13	--
Price / Book Value	0.30	1.20	0.94	0.43	0.85	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-50.88	630.41	50.79	20.26	115.37	2,742.36
Close Price (₹)	3.75	14.84	10.21	4.64	9.04	--
High Price (₹)	13.84	18.30	14.85	10.86	34.15	--
Low Price (₹)	3.04	9.20	4.46	4.35	8.00	--
Market Cap (₹ Cr)	9.18	38.26	11.61	5.28	10.28	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	0.01	0.01	0.01	0.01	0.03
Short term debt to equity ratio	--	0.01	0.01	0.01	0.01	0.03
Current Ratio	0.86	1.06	1.46	1.67	3.78	4.57
Quick Ratio	0.86	1.03	1.42	0.96	3.56	4.43
Interest Coverage	--	68.30	247.22	205.48	98.67	7.14

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	585.76	67.84	36.01	50.08	102.20	392.86
Asset Turnover	0.02	0.30	0.89	0.10	0.04	0.01
Receivable days	--	230.35	74.19	163.04	382.81	1,569.88
Inventory Days	--	7.16	14.53	141.34	41.83	152.85
Payable days	--	235.95	73.58	215.60	28.57	--
Cash Conversion Cycle	--	1.56	15.13	88.78	396.08	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.